SignalXSignalX

LNTH Lantheus Holdings, Inc.

8-K Current Report
Filed: February 26, 2026
Health Care
In Vitro & In Vivo Diagnostic Substances
Lantheus Holdings, Inc. Overview

Lantheus Holdings, Inc. (LNTH) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Q4 and full-year 2025 results announced Feb 26, 2026 — covering period ended December 31, 2025
  • • Full financials in Exhibit 99.1 press release; no key figures disclosed in the 8-K filing text itself

Get deeper insights on Lantheus Holdings, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.